These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 20416367

  • 1. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W, Chen X, Yang L, Mao Y, Wei Y, Chen L.
    Int J Pharm; 2010 Jun 30; 393(1-2):119-26. PubMed ID: 20416367
    [Abstract] [Full Text] [Related]

  • 2. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.
    J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599
    [Abstract] [Full Text] [Related]

  • 3. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
    Han L, Huang R, Li J, Liu S, Huang S, Jiang C.
    Biomaterials; 2011 Feb 01; 32(4):1242-52. PubMed ID: 20971503
    [Abstract] [Full Text] [Related]

  • 4. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 5. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.
    Int J Pharm; 2009 Dec 01; 382(1-2):254-61. PubMed ID: 19666094
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW.
    Cancer Res; 2000 Dec 15; 60(24):6950-7. PubMed ID: 11156395
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K, Un K, Tanaka K, Higaki K, Kimura T.
    J Control Release; 2009 Jan 05; 133(1):4-10. PubMed ID: 18840484
    [Abstract] [Full Text] [Related]

  • 12. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
    Peng XC, Yang L, Yang LP, Mao YQ, Yang HS, Liu JY, Zhang DM, Chen LJ, Wei YQ.
    J Exp Clin Cancer Res; 2008 Sep 25; 27(1):46. PubMed ID: 18816410
    [Abstract] [Full Text] [Related]

  • 13. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
    Zou Y, Zong G, Ling YH, Perez-Soler R.
    Cancer Gene Ther; 2000 May 25; 7(5):683-96. PubMed ID: 10830716
    [Abstract] [Full Text] [Related]

  • 14. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C, Zhao L, Dong Y, Zhang X, Lin J, Chen Z.
    Eur J Pharm Biopharm; 2010 Sep 25; 76(1):10-6. PubMed ID: 20472060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL, Rauth AM, Bendayan R, Wu XY.
    Eur J Pharm Biopharm; 2007 Mar 25; 65(3):300-8. PubMed ID: 17156986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy.
    Fonseca MJ, Storm G, Hennink WE, Gerritsen WR, Haisma HJ.
    J Gene Med; 1999 Mar 25; 1(6):407-14. PubMed ID: 10753066
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
    Mizuno Y, Naoi T, Nishikawa M, Rattanakiat S, Hamaguchi N, Hashida M, Takakura Y.
    J Control Release; 2010 Jan 25; 141(2):252-9. PubMed ID: 19778560
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
    Yang W, Li XY.
    Chin Med J (Engl); 2005 Feb 20; 118(4):296-301. PubMed ID: 15740667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.